Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population

Completed

Conditions studied: Severe Combined Immunodeficiency, T Cell Lymphocytopenia

In brief

The goal of the proposed research is to establish the validity of a newborn screening method for severe combined immunodeficiency (SCID). The assay to be used is developed on the basis of PCR quantification of T-cell receptor excision circles (TRECs) that is absent in SCID patients, thus correlating with the disease

Key facts

Study ID

NCT00845416

Run by

University of California, San Francisco

People needed

1800

Starts

2009-03-01

Expected to finish

2011-11-01

Last updated by the study team

2012-07-16

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Birth in a study hospital on the Navajo Reservation

You may not qualify if…

• None

Where it is running

• Chinle Hospital — Chinle, Arizona, United States
• Tuba City Hospital — Tuba City, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.